HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Results of the combined U.S. Multicenter Pivotal Study and the Continuing Access Study of the Nit-Occlud PDA device for percutaneous closure of patent ductus arteriosus.

AbstractOBJECTIVES:
This study aimed to compare the efficacy and safety of the Nit-Occlud PDA device (PFM Medical, Cologne, Germany) to benchmarks designed as objective performance criteria (OPC).
BACKGROUND:
The Nit-Occlud PDA is a nitinol coil-type patent ductus arteriosus (PDA) occluder with a reverse cone configuration, which is implanted using a controlled delivery system.
METHODS:
Patients with <4-mm minimum diameter PDA were prospectively enrolled in the Pivotal and the Continuing Access Studies from 15 sites in the United States and were followed up for 12 months post-procedure. Investigator-reported outcomes were compared to OPC including a composite success criterion, efficacy criteria of successful closure (clinical and echocardiographic), and safety criteria incidence of adverse events (serious and of total).
RESULTS:
The Pivotal Study enrolled patients between November 1, 2002 and October 31, 2005, and the Continuing Access Study enrolled additional patients between September 1, 2006 and October 31, 2007. A total of 357 patients were enrolled, and 347 had successful device implantations. After 12 months, 96.8% had complete echocardiographic closure (OPC = 85%) and 98.1% had clinical closure (OPC = 95%). There were no deaths or serious adverse events (OPC = 1%). The total adverse event rate was 4.7% (OPC = 6%). Composite success was 95.1% in the study patients (OPC = 80%).
CONCLUSIONS:
Closure of small- and medium-sized PDA with the Nit-Occlud PDA is effective and safe when compared with OPC.
AuthorsJohn W Moore, Jessica Greene, Salvadore Palomares, Alexander Javois, Carl Y Owada, John P Cheatham, Mark H Hoyer, Thomas K Jones, Daniel S Levi, Pivotal and Continuing Access Studies of the Nit Occlud PDA Investigators
JournalJACC. Cardiovascular interventions (JACC Cardiovasc Interv) Vol. 7 Issue 12 Pg. 1430-6 (Dec 2014) ISSN: 1876-7605 [Electronic] United States
PMID25523534 (Publication Type: Clinical Trial, Journal Article, Multicenter Study)
CopyrightCopyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Alloys
  • nitinol
Topics
  • Adolescent
  • Alloys
  • Cardiac Catheterization (adverse effects, instrumentation)
  • Child
  • Child, Preschool
  • Ductus Arteriosus, Patent (diagnosis, therapy)
  • Female
  • Humans
  • Infant
  • Male
  • Prospective Studies
  • Prosthesis Design
  • Risk Factors
  • Time Factors
  • Treatment Outcome
  • United States
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: